We are delighted to announce that Oximio Israel has been successfully awarded yet another import license for Compassionate use program in January 2023. “Compassionate use” allows for a patient outside of clinical trials with a serious or life-threatening disease to...

We are delighted to share that expansion of our global bonded depot network continues.  We have successfully received the bonded depot license this week for our Serbia facility. This opens a route for imports of bulk shipments and distribution from our depot in...

As Oximio patient centricity services continue to expand, we are delighted to announce that the first home healthcare visit in Israel took place week commencing 9th of January 2023.The services allow for the nurses to collect the bio-samples from the patients’...

  Following the announcement of 8th December 2022, the Board of Oximio confirms the appointment of Mykola Nikolaiev as the new Chief Executive Officer (CEO). Accordingly, Krisztina Varga has resigned from the Board as CEO and Mykola Nikolaiev takes over the...

Following the crisis in Ukraine, Oximio has resumed some operations, knowing that previously established supply chains and logistics models are no longer feasible. This is given to the destruction of infrastructure, stock limitations, and most importantly, as we...

The new clinical trial logistics hub reaches research sites in East, Central and West Africa faster and at a reduced cost, compared with established supply chain models Huntingdon, United Kingdom (March 10, 2022) – Oximio is changing the landscape of clinical trials...

Oximio’s transport coverage in Ukraine. View the latest map here.   Update 13.10.22 Our colleagues continue to work onsite at the depots, processing imports, inbounds and outbounds. Note that our operations will be closed tomorrow, on Friday 14 October, as it is...

Expanded access programs (EAPs), have been in and out of the pharmaceutical spotlight since their inception back in the late 1970s. While a formal EA program was first established in 1987 in response to HIV/AIDS, it wasn’t until the 2013 Ebola virus outbreak that the...

Based on our experience of implementing comparator sourcing strategy to meet studies’ increasing complexity, Oximio held a webinar to explore this topic further and provide actionable insight for our participants. Below is a short summary of the questions asked by our...